- Home
- MSGE vs DYN Comparison
MSGE vs DYN Comparison
Compare MSGE & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSGE
- DYN
- Stock Information
- Founded
- MSGE 2020
- DYN 1984
- Country
- MSGE United States
- DYN United States
- Employees
- MSGE N/A
- DYN N/A
- Industry
- MSGE Services-Misc. Amusement & Recreation
- DYN Medicinal Chemicals and Botanical Products
- Sector
- MSGE Consumer Discretionary
- DYN Health Care
- Exchange
- MSGE Nasdaq
- DYN Nasdaq
- Market Cap
- MSGE 1.4B
- DYN 1.3B
- IPO Year
- MSGE N/A
- DYN 2020
- Fundamental
- Price
- MSGE $37.25
- DYN $12.70
- Analyst Decision
- MSGE Strong Buy
- DYN Strong Buy
- Analyst Count
- MSGE 6
- DYN 13
- Target Price
- MSGE $49.83
- DYN $45.92
- AVG Volume (30 Days)
- MSGE 256.3K
- DYN 2.5M
- Earning Date
- MSGE 05-06-2025
- DYN 05-08-2025
- Dividend Yield
- MSGE N/A
- DYN N/A
- EPS Growth
- MSGE 157.00
- DYN N/A
- EPS
- MSGE 2.72
- DYN N/A
- Revenue
- MSGE $974,670,000.00
- DYN N/A
- Revenue This Year
- MSGE $0.42
- DYN N/A
- Revenue Next Year
- MSGE $6.30
- DYN N/A
- P/E Ratio
- MSGE $13.66
- DYN N/A
- Revenue Growth
- MSGE 5.81
- DYN N/A
- 52 Week Low
- MSGE $28.29
- DYN $6.36
- 52 Week High
- MSGE $44.14
- DYN $47.45
- Technical
- Relative Strength Index (RSI)
- MSGE 60.63
- DYN 60.66
- Support Level
- MSGE $36.43
- DYN $11.51
- Resistance Level
- MSGE $37.30
- DYN $12.34
- Average True Range (ATR)
- MSGE 0.73
- DYN 0.75
- MACD
- MSGE -0.20
- DYN 0.02
- Stochastic Oscillator
- MSGE 37.10
- DYN 86.93
About MSGE Madison Square Garden Entertainment Corp.
Madison Square Garden Entertainment Corp provides live entertainment, delivering unforgettable experiences while forging deep connections with diverse and passionate audiences. The company's portfolio includes a collection of world-renowned venues - New York's Madison Square Garden, The Theater at Madison Square Garden, Radio City Music Hall, and Beacon Theatre; and The Chicago Theatre - that showcase a broad array of sporting events, concerts, family shows, and special events for millions of guests annually. In addition, the company features the original production, the Christmas Spectacular Starring the Radio City Rockettes, which has been a holiday tradition for 89 years.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.